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A simple, fast and reproducible method for the determination of proguanil using high performance 
liquid chromatographic with UV/Fluorescence detection is described. Proguanil was derivatised to its 
corresponding derivative [(N1-(4-chlorophenyl)-N5-(1 -methyl ethyl) imidocarbonimideamide-N-
benzoxazole]. The derivatisation reaction was conducted in methanol at 60°C using sodium 
benzoxazole-2-sulphonate under alkaline conditions. The resulting derivative was extracted with 
chloroform after which the extract was observed under UV lamp at 254 nm before TLC and HPLC 
analysis. Similarly, the derivatisation process was adapted for derivatisation of proguanil in urine 
sample. The reaction proceeded smoothly and rapidly. The extraction process was not cumbersome 
and eliminated the need for costly extraction and evaporation equipments. The resulting derivative 
fluorensced intensely under UV lamp. Direct HPLC analysis of the reaction mixture was found possible 
without interferences from excess reagent and endogeneous compounds like ammonium salts. The 
derivative eluted in less than seven minutes thus making the method suitable for routine use. The 
calibration plot was linear over the concentration range. A correlation regression of the order of 0.94 
was obtained from the calibration curve which indicated a strong relationship between the instrument 
response and the concentration of proguanil. The discussion also summarizes the derivatisation 
chemistry that have not being fully explored to date but may find utility in future development of highly 
sensitive analytical methods for biquanide drugs. 
 





Proguanil, a biguanide derivative of pyrimidine is the 
most active of a series of synthetic aryl biguanides com-
pounds tested for antimalarial activity in the mid 1940s 
(Curd et al., 1945). Proguanil was demonstrated to be 
both efficacious and non toxic hence its wide use as a 
prophylactic anti-malarial (Wattanagoon et al., 1987). The 
use of proguanil in the prophylaxis and treatment of 
malaria has increased recently due to the emergence of 
chloroquine resistant Plasmodium falciparum. The use of 
proguanil in combination with other antimalarial drugs has 
also been reported to posses synergic toxicity on the 
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The pharmacokinetic characteristics of a drug have been 
implicated in the mechanism through which parasites 
develop resistance to it (Moody et al., 1982). The elucida-
tion of the pharmacokinetic characteristic of proguanil is 
therefore necessary if its continued use and potency is 
not to be forfeited. The determination of proguanil, titrime-
tically (Stagg, 1947; Gallo et al., 1955) gravimetrically 
(Green and Babru, 1972) and colorimetrically (Meagraith 
et al., 1946) and microbially (Smith et al., 1961) are 
lacking both in specificity and sensitivity and are therefore 
of no use for the pharmacokinetic study on proguanil. 
There are however a few chromatographic methods with 
the advantage of specificity and sensitivity. The pioneering 
chromatographic work by Moody et al. (1982) utilized 
reverse phase ion pairing high performance liquid chro-





its two major metabolites cycloguanil and 4 -chloro 
phenyl biguanide. A detection limit of 60 ng/ml of sample 
volume was achieved with the method. Edstein (1986) in 
his work achieved a better sensitivity of 25 ng/ml sample 
volume.  
The modifications made to the methods described by 
Moody et al. (1982) included the extraction procedure 
and a change in the ion pairing agent from sodium lauryl 
sulphate to pentane sulphonic acid. Kelly and Fletcher 
(1986) also made slight modifications to the liquid extrac-
tion procedures of Moody et al. (1982) and the ion pairing 
agent to achieve improved sensitivity. Taylor et al. (1987) 
however utilized solid phase extraction procedure in the 
pretreatment of samples but retained the sodium lauryl 
sulphate ion pairing agent. Other works by Taylor et al. 
(1990), Bergqvist and Hosptadius (2000), Kolawole et al. 
(1995), Bergqvist et al. (1998), either aimed at the 
determination of proguanil when used in combination with 
other antimalarial drugs or from very small sample volumes 
with little or no modifications above described methods. 
It must however be stated that there are some 
inconsistencies in the analytical data on proguanil from 
the above methods hence the report that proguanil has 
limited pharmacokinetic data in literature by the WHO 
informal consultation on the use of antimalarial drugs 
(2001). It is in the light of this that this work sets to 
develop a method which is specific sensitive and repro-
ducibly determines proguanil. This is hoped to be achieved 
by derivatizing proquanil with sodium benzoxazole-2-
sulphonate and the resulting derivative determined by 




MATERIALS AND METHODS 
 
Reagents and chemicals  
 
Reagents and chemicals used in this study include proguanil 
hydrochloride powder (ICI), proguanil hydrochloride tablet (Astra 
Zeneca) high performance liquid chromatography (HPLC) grade 
acetonitrile (BDH), HPLC grade methanol (sigma) sodium benzoxa-





The chromatographic apparatus consisted of a Cecil 1200 series 
1000 high performance liquid chromatograph. The analytical 
column was ODS hypersil C18,5 µm particle size in 250 mm length x 
4.6 mm I.D stainless steel column. The mobile phase consisted of 
acetonitrile/ water 65:35 v/v. The flow rate was 1 ml/min and column 
temperature was maintained at 25°C with detection at 254 nm. 
 
 
Preparation of sodium benzoxazole- 2 -sulphonate 
 
Sodium benzoxazole-2-sulphonate was synthesized following the 
procedure described by Idowu and Adewuyi (1993). Using the 
procedure, a mixture made of O-aminophenol (15.0 g), 75 ml 
methanol, a solution of 10 g potassium hydroxide in 20 ml distilled 
water and  50 ml  carbon  disulphide  was  refluxed  for  2.5 h  after  




which another 30 - 50 ml portion of carbon disulphide was added. 
After refluxing for about 30 min, the mixture was allowed to cool to 
room temperature and decolourising charcoal was added. After 
refluxing for another 10 - 15 min, the mixture was filtered through 
flutted filter paper. The filtrate was distilled to dryness and the 
residue dissolved in 100 ml of water and the solution treated with a 
solution of 30 ml glacial acetic acid mixed with equal volume of 
water. 2-Mercaptobenzoxazole was immediately precipitated as a 
whitish solid. The solid was filtered and dried in air. 
2-Mercaptobenzoxazole (5.0 g) was mixed with about 15 g phos-
phorus pentachloride and mixture heated on boiling water bath for 1 
h. The mixture was then transferred to a hot plate and refluxed for 
another 1.5 h. After cooling to room temperature, the mixture was 
treated with 50 ml of a 25% (w/v) solution of sodium sulphate. After 
the vigorous effervescence had stopped, 50 ml sodium sulphate 
solution was further added and the mixture refluxed for 2 h by 
heating on a hot plate. The mixture was then filtered hot through 
flutted filter paper. As the solution cooled, needle shaped crystals of 
sodium-benzoxazole-2-sulphonate were formed. 
 
 
Preparation of benzoxazole derivative of proguanil 
 
Proguanil (0.1 g) was dissolved in 2.0 ml of methanol and added to 
a solution of 0.1 g sodium banzoxazole- 2 -sulphonate in 5.0 ml of 
methanol and 1.0 ml 5 M sodium hydroxide solution added. After 
warming in a water bath (60°C) for 5 min (Figure 1), the solution 
was observed under U.V. light. After cooling, the mixture was 
extracted with 5 ml chloroform. The aqueous layer was removed 
with a Pasteur pipette and the chloroform dried with anhydrous 
sodium sulphate. The chloroform extract was then transferred to 
another test tube and the chloroform removed under a stream of 
nitrogen. The residue was then reconstituted in 1 ml methanol and 
examined under the UV light before thin layer chromatography 





Preparation of stock solution of proquanil: Stock solution 
containing 100ug/ml proguanil was prepared in distilled water. 
 
Calibration curve in blank urine sample: Using four extraction 
tubes, 1 ml blank urine samples were introduced, after which, 
varying amounts of the stock solution (100 µl/ml) of proguanil were 
added to give calibration ranges between 0 - 6 µl/ml for proguanil . 
100 µl of sodium benzoxazole- 2 -sulphonate solution in methanol 
was added to each of the test tube, the mixture were rendered 
alkaline with 2 M NaOH (0.5 ml) and whirlmixed for 1 min then 
warmed at 60°C for 5 min. The mixture was allowed to cool after 
which 3 ml chloroform was added to each of the samples and the 
tubes were centrifuge at 1500 rpm for 5 min. The chloroform layer 
was aspirated into another tube and dried over sodium sulphate 
crystals. The extraction with chloroform was repeated twice. The 
pooled extract was evaporated to dryness in a water bath at 40°C 
.The residue was reconstituted in 100 µl of methanol and whirl-
mixed before 20 µl was injected onto the HPLC .  
 
 
RESULTS AND DISCUSSION  
 
An ideal derivatisation reagent for HPLC with UV or 
fluorescence detection should possess certain charac-
teristics. Its UV or fluorescence characteristics should be 
completely different from that of the derivative so that 
excess reagent will not interfere with the detection  of  the  
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derivative. Alternatively, if the reagent and the derivative 
have similar spectral characteristic, their chromatography 
behaviours should be widely different to allow easy 
separation of the excess reagent from the derivative. If 
this cannot be achieved by simple solvent extraction, the 
reagent should react readily with the analyte without any 
complicating side reactions such as undesirable hydro-
lytic decomposition which is observed with some rea-
gents during derivatisation reactions with proguanil. Also, 
the derivative should be stable to light. Furthermore, it 
should be possible to carry out the derivatisation reaction 
in a variety of solvents and solvent combination that are 
to be encountered during the intended chromatographic 
applications. These are important requirements if the 
reagent is to be applicable to on-line pre or post column 
derivatisation in a possible automation of the analytical 
method. Proguanil consist of a biguanide with two substi-
tuents p-chloro benzene and isopropyl groups at N1 and 
N5 positions. The basic structure of proguanil is respon-
sible for its polar nature which is similar for all biguanide 
drugs. Biguanides are therefore strong bases. The polar 
nature creates problem of isolation and determination as 
is experienced for proguanil. However, the reaction of 
proguanil with a water soluble fluorescent reagent like 
sodium benzoxazole-2-sulphonate is expected to 
produce a derivative that fluorensced intensely and can 
be determined with ease. The observation of the deriva-
tised solution under a UV light gave an intensed blue 
colouration which was not observed with proguanil. This 
was an indication that fluorescence derivative resulted 
from the reaction. 
Thin layer chromatography was done to establish the 
chromatographic behaviours. The derivative was detec-
table at low microgram level by TLC followed by exami-
nation of the plate under UV light. The RF of derivative 
was 0.48; while sodium benzoxazole-2-sulphonate gave 
RF of 0.98. The retention value for benzoxazole was con-
sistent with the observation of Idowu and Adewuyi 
(1993). The derivative being a large molecule had a 
retention value of 0.48 which was expected and in agree-
ment with previous observation. This chromatographic 
behaviour is note worthy because it revealed that excess 
derivatising reagent would not interfere with detection.  
 
 
Determination of proguanil in urine 
 
Chromatographic separation was carried out under 
gradient condition at ambient temperature on a reversed 
phase column (ODS Hypersil) with UV/FL wavelength at 
254 nm. A mobile phase consisting of acetonitrile - water 
(65:35 v/v) at a flow rate of 1.0 ml/min was found to be 
suitable. A representative liquid chromatographic sepa-
ration of the derivatized proquanil in urine is reported in 
Figure 2. The figure revealed that the reagent and solvent 
did not interfere with the analysis. Also, there were no 
interferences from endogenous compounds in the urine 
sample used in the study, thereby facilitating accurate 
determination of the drug. The method gave good 
recovery for derivatized proquanil (> 90%) in urine (Table 
1).This is an improvement over previous method reported 
(Eldstein, 1986; Taylor et al., 1987) and this report 
corresponds with the observation of Ebeshi et al. (2005). 
The HPLC method was reproducible with coefficient of 
variation (which is a measure of precision) being less 
than 10% in urine (Table 2). 
Therefore, the method exhibits good precision and 
sensitivity. The calibration curve using solution with known 
concentration of derivatized proguanil was linear with 
correlation coefficient of not less  than  0.94  (Figure 3)  in  










Table 1. Precision of analytical method for derivatized proquanil in urine. 
 
Coefficient of variation   0/0 Conc. 
(µ/ml) 
Number of 
samples (n) PGB1 PGA2 PGA3 PGA4 
0 4 4.26 5.35 4.20 3 - 28 
2 4 3.20 4.82 3.82 4.14 
4 4 5.28 3.45 2.86 2.46 
6 4 6.12 4.23 5.14 4.34 
 




Table 2. Peak area ratio and correlation coefficient for 
derivatized proguanil in urine. 
 





y = 11.45x - 0.9774 
R2 =  0.9418 
the urine sample used in the study. A similar trend was 
observed by Ebeshi et al. (2005) in their study in which 
the calibration curve for proguanil was linear with corre-
lation of not less than 0.9.  
The method may be further developed to address the 
challenge of simultaneous determination of proguanil and 
its major metabolites due to the presence of a primary 
amino functionality on both cycloguanil and 4-chloro-
phenylbiguanide that could  be  derivatised  with  sodium- 










benzoxazole-2-sulphonate and hence reduce the paucity 
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